Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00173771
Status:
UNKNOWN
Last Update Posted:
2005-09-15
First Post:
2005-09-13
Brief Title:
Development of a Comprehensive ADL Scale for Stroke Patients
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Development of a Comprehensive ADL Scale for Stroke Patients
Status:
UNKNOWN
Status Verified Date:
2005-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
our research team will develop a new CADL scale for stroke patients over the next three years
In the first year we had established a CADL item bank of 50 items The investigators will administer the 50 items on 300 patients with stroke living in the community Then we will select 10 to 15 items from the item bank for the CADL scale based on the International Classification of Functioning Disability and Health ICF the opinions of an expert panel and Rasch analysis It is anticipated that the CADL scale will have unidimensionality an interval level of measurement soundly psychometric characteristics a reduced number of items and ease of administration
In the second and third years we will compare the psychometric properties of the CADL scale and the combined BI and FAI scale The psychometric properties investigated will include reliability eg inter-rater reliability intra-rater reliability and internal consistency validity eg concurrent validity convergent validity predictive validity and discriminant validity and responsiveness A total of 150 patients will be recruited Both the CADL scale and the combined BI and FAI scale will be used on patients from the initial stage within one month to six months after hospital discharge The results will be useful for researchers and clinicians to determine whether the CADL scale is better than the combined BI and FAI scale in stroke patients
In the first year we had established a CADL item bank of 50 items The investigators will administer the 50 items on 300 patients with stroke living in the community Then we will select 10 to 15 items from the item bank for the CADL scale based on the International Classification of Functioning Disability and Health ICF the opinions of an expert panel and Rasch analysis It is anticipated that the CADL scale will have unidimensionality an interval level of measurement soundly psychometric characteristics a reduced number of items and ease of administration
In the second and third years we will compare the psychometric properties of the CADL scale and the combined BI and FAI scale The psychometric properties investigated will include reliability eg inter-rater reliability intra-rater reliability and internal consistency validity eg concurrent validity convergent validity predictive validity and discriminant validity and responsiveness A total of 150 patients will be recruited Both the CADL scale and the combined BI and FAI scale will be used on patients from the initial stage within one month to six months after hospital discharge The results will be useful for researchers and clinicians to determine whether the CADL scale is better than the combined BI and FAI scale in stroke patients
Detailed Description:
our research team will develop a new CADL scale for stroke patients over the next three years
In the first year an ongoing project NSC 93-2314-B-002-284 we had established a CADL item bank of 50 items The investigators will administer the 50 items on 300 patients with stroke living in the community Then we will select 10 to 15 items from the item bank for the CADL scale based on the International Classification of Functioning Disability and Health ICF the opinions of an expert panel and Rasch analysis It is anticipated that the CADL scale will have unidimensionality an interval level of measurement soundly psychometric characteristics a reduced number of items and ease of administration
In the second and third years we will compare the psychometric properties of the CADL scale and the combined BI and FAI scale The psychometric properties investigated will include reliability eg inter-rater reliability intra-rater reliability and internal consistency validity eg concurrent validity convergent validity predictive validity and discriminant validity and responsiveness A total of 150 patients will be recruited Both the CADL scale and the combined BI and FAI scale will be used on patients from the initial stage within one month to six months after hospital discharge The results will be useful for researchers and clinicians to determine whether the CADL scale is better than the combined BI and FAI scale in stroke patients
In the first year an ongoing project NSC 93-2314-B-002-284 we had established a CADL item bank of 50 items The investigators will administer the 50 items on 300 patients with stroke living in the community Then we will select 10 to 15 items from the item bank for the CADL scale based on the International Classification of Functioning Disability and Health ICF the opinions of an expert panel and Rasch analysis It is anticipated that the CADL scale will have unidimensionality an interval level of measurement soundly psychometric characteristics a reduced number of items and ease of administration
In the second and third years we will compare the psychometric properties of the CADL scale and the combined BI and FAI scale The psychometric properties investigated will include reliability eg inter-rater reliability intra-rater reliability and internal consistency validity eg concurrent validity convergent validity predictive validity and discriminant validity and responsiveness A total of 150 patients will be recruited Both the CADL scale and the combined BI and FAI scale will be used on patients from the initial stage within one month to six months after hospital discharge The results will be useful for researchers and clinicians to determine whether the CADL scale is better than the combined BI and FAI scale in stroke patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NSC-94-2314-B-002-076 | None | None | None |